These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7413018)

  • 1. Effect of chronic intracerebroventricular angiotensin II infusion on vasopressin release in rats.
    Sterling GH; Chee O; Riggs RV; Keil LC
    Neuroendocrinology; 1980 Sep; 31(3):182-8. PubMed ID: 7413018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin, fluid, and electrolyte response to chronic angiotensin II infusion.
    Cowley AW; Switzer SJ; Skelton MM
    Am J Physiol; 1981 Mar; 240(3):R130-8. PubMed ID: 7212084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracerebroventricular deuterium oxide on water intake and AVP release induced by intravenous infusion of angiotensin II in sheep.
    Hjelmqvist H; Rundgren M
    Acta Physiol Scand; 1990 Feb; 138(2):155-60. PubMed ID: 2156405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium depletion and angiotensin II on osmotic regulation of vasopressin.
    Wade CE; Keil LC; Ramsay DJ
    Am J Physiol; 1986 Feb; 250(2 Pt 2):R287-91. PubMed ID: 3946642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.
    Kimura T; Abe K; Ota K; Omata K; Shoji M; Kudo K; Matsui K; Inoue M; Yasujima M; Yoshinaga K
    J Clin Endocrinol Metab; 1986 May; 62(5):1003-10. PubMed ID: 2937798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral sodium/angiotensin interaction studied by RIA-determination of urinary arginine vasopressin in the hydrated goat.
    Lishajko F; Appelgren B; Eriksson S
    Acta Physiol Scand; 1981 Mar; 111(3):311-8. PubMed ID: 7315399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deuterium induced extinction of ADH-release in response to intracerebroventricular infusions of hypertonic NaCl and angiotensin.
    Rundgren M; Leksell LG; Lishajko F; Andersson B
    Acta Physiol Scand; 1977 May; 100(1):45-50. PubMed ID: 899828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
    Watanabe T; Oki Y; Orth DN
    Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women.
    Stachenfeld NS; DiPietro L; Palter SF; Nadel ER
    Am J Physiol; 1998 Jan; 274(1):R187-95. PubMed ID: 9458917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for the subfornical organ in vasopressin release.
    Mangiapane ML; Thrasher TN; Keil LC; Simpson JB; Ganong WF
    Brain Res Bull; 1984 Jul; 13(1):43-7. PubMed ID: 6478269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is vasopressin an important hypertensive hormone?
    Lohmeier TE; Smith MJ; Cowley AW; Manning RD; Guyton AC
    Hypertension; 1981; 3(4):416-25. PubMed ID: 7309205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmotic thirst and vasopressin release in humans: a double-blind crossover study.
    Phillips PA; Rolls BJ; Ledingham JG; Forsling ML; Morton JJ
    Am J Physiol; 1985 Jun; 248(6 Pt 2):R645-50. PubMed ID: 4003573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hypertonic saline causes transient fall of vasopressin in humans.
    Seckl JR; Williams TD; Lightman SL
    Am J Physiol; 1986 Aug; 251(2 Pt 2):R214-7. PubMed ID: 3740301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragastric hypertonic saline increases vasopressin and central Fos immunoreactivity in conscious rats.
    Carlson SH; Beitz A; Osborn JW
    Am J Physiol; 1997 Mar; 272(3 Pt 2):R750-8. PubMed ID: 9087636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats.
    Yamaguchi K; Hama H; Watanabe K
    Eur J Endocrinol; 1996 Feb; 134(2):243-50. PubMed ID: 8630527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic physiological increases in cortisol inhibit the vasopressin response to hypertonicity in conscious dogs.
    Papanek PE; Raff H
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1342-9. PubMed ID: 7977863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic intraventricular administration of angiotensin II on drinking behavior and blood pressure.
    Gronan RJ; York DH
    Pharmacol Biochem Behav; 1979 Jan; 10(1):121-6. PubMed ID: 441088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role of angiotensin in the hyperosmolality- and hypovolaemia-induced vasopressin release in conscious rats.
    Yamaguchi K; Sakaguchi T; Kamoi K
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):524-30. PubMed ID: 7158228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.